MERS Vaccine Candidate Offers Promise, but Questions Remain

von Menachery, Vineet D.
Veröffentlicht in EBioMedicine (2015)

Bugs in the system

von Menachery, Vineet D., Baric, Ralph S.
Veröffentlicht 2013

Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism

von Schindewolf, Craig, Menachery, Vineet D.
Veröffentlicht in Viruses (2019)

Catch Me if You Can: Superspreading of COVID-19

von Lakdawala, Seema S., Menachery, Vineet D.
Veröffentlicht in Trends Microbiol (2021)

Control of Herpes Simplex Virus Replication Is Mediated through an Interferon Regulatory Factor 3-Dependent Pathway

von Menachery, Vineet D., Leib, David A.
Veröffentlicht 2009

Return of the Coronavirus: 2019-nCoV

von Gralinski, Lisa E., Menachery, Vineet D.
Veröffentlicht in Viruses (2020)

Coagulation and wound repair during COVID-19

von Menachery, Vineet D., Gralinski, Lisa E.
Veröffentlicht in J Heart Lung Transplant (2021)

Coronavirus non-structural protein 16: Evasion, attenuation, and possible treatments

von Menachery, Vineet D., Debbink, Kari, Baric, Ralph S.
Veröffentlicht in Virus Res (2014)

Jumping species—a mechanism for coronavirus persistence and survival

von Menachery, Vineet D, Graham, Rachel L, Baric, Ralph S
Veröffentlicht in Curr Opin Virol (2017)

Interferon Regulatory Factor 3-Dependent Pathways Are Critical for Control of Herpes Simplex Virus Type 1 Central Nervous System Infection

von Menachery, Vineet D., Pasieka, Tracy Jo, Leib, David A.
Veröffentlicht 2010

Viral metagenomics, protein structure, and reverse genetics: Key strategies for investigating coronaviruses

von Johnson, Bryan A., Graham, Rachel L., Menachery, Vineet D.
Veröffentlicht in Virology (2018)

New Metrics for Evaluating Viral Respiratory Pathogenesis

von Menachery, Vineet D., Gralinski, Lisa E., Baric, Ralph S., Ferris, Martin T.
Veröffentlicht in PLoS One (2015)

Corneal Replication Is an Interferon Response-Independent Bottleneck for Virulence of Herpes Simplex Virus 1 in the Absence of Virion Host Shutoff

von Pasieka, Tracy Jo, Menachery, Vineet D., Rosato, Pamela C., Leib, David A.
Veröffentlicht 2012

Shortening of Zika virus CD-loop reduces neurovirulence while preserving antigenicity

von Dinnon III, Kenneth H., Gallichotte, Emily N., Fritch, Ethan J., Menachery, Vineet D., Baric, Ralph S.
Veröffentlicht in PLoS Negl Trop Dis (2019)

The variant gambit: COVID-19’s next move

von Plante, Jessica A., Mitchell, Brooke M., Plante, Kenneth S., Debbink, Kari, Weaver, Scott C., Menachery, Vineet D.
Veröffentlicht in Cell Host Microbe (2021)

Novel Ionophores Active against La Crosse Virus Identified through Rapid Antiviral Screening

von Sandler, Zachary J., Firpo, Mason R., Omoba, Oreoluwa S., Vu, Michelle N., Menachery, Vineet D., Mounce, Bryan C.
Veröffentlicht in Antimicrob Agents Chemother (2020)

Engineering SARS-CoV-2 using a reverse genetic system

von Xie, Xuping, Lokugamage, Kumari G., Zhang, Xianwen, Vu, Michelle N., Muruato, Antonio E., Menachery, Vineet D., Shi, Pei-Yong
Veröffentlicht in Nat Protoc (2021)

Attenuation and Restoration of Severe Acute Respiratory Syndrome Coronavirus Mutant Lacking 2′-O-Methyltransferase Activity

von Menachery, Vineet D., Yount, Boyd L., Josset, Laurence, Gralinski, Lisa E., Scobey, Trevor, Agnihothram, Sudhakar, Katze, Michael G., Baric, Ralph S.
Veröffentlicht 2014

Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform

von Agnihothram, Sudhakar, Menachery, Vineet D., Yount, Boyd L., Lindesmith, Lisa C., Scobey, Trevor, Whitmore, Alan, Schäfer, Alexandra, Heise, Mark T., Baric, Ralph S.
Veröffentlicht in J Virol (2018)

Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV.

von Lokugamage, Kumari G., Hage, Adam, de Vries, Maren, Valero-Jimenez, Ana M., Schindewolf, Craig, Dittmann, Meike, Rajsbaum, Ricardo, Menachery, Vineet D.
Veröffentlicht in bioRxiv (2020)